ProPhase Labs Inc (PRPH)
2.19
+0.05
(+2.34%)
USD |
NASDAQ |
Nov 04, 16:00
2.19
0.00 (0.00%)
After-Hours: 20:00
ProPhase Labs Profit Margin (Quarterly): -248.7% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -248.7% |
| March 31, 2024 | -172.4% |
| December 31, 2023 | -250.1% |
| September 30, 2023 | -61.46% |
| June 30, 2023 | -26.03% |
| March 31, 2023 | 2.85% |
| December 31, 2022 | -11.20% |
| September 30, 2022 | 4.00% |
| June 30, 2022 | 25.59% |
| March 31, 2022 | 26.29% |
| December 31, 2021 | 23.45% |
| September 30, 2021 | -42.00% |
| June 30, 2021 | -15.26% |
| March 31, 2021 | 6.92% |
| December 31, 2020 | -18.94% |
| September 30, 2020 | -10.62% |
| June 30, 2020 | 1.93% |
| March 31, 2020 | -42.85% |
| December 31, 2019 | -14.87% |
| September 30, 2019 | -15.47% |
| June 30, 2019 | -74.98% |
| March 31, 2019 | -43.70% |
| December 31, 2018 | -11.41% |
| September 30, 2018 | -43.34% |
| June 30, 2018 | -8.13% |
| Date | Value |
|---|---|
| March 31, 2018 | 1.26% |
| December 31, 2017 | -5.20% |
| September 30, 2017 | -25.56% |
| June 30, 2017 | -121.0% |
| March 31, 2017 | |
| December 31, 2016 | -74.58% |
| September 30, 2016 | 11.91% |
| June 30, 2016 | -110.4% |
| March 31, 2016 | -131.5% |
| December 31, 2015 | 12.66% |
| September 30, 2015 | 13.71% |
| June 30, 2015 | -71.47% |
| March 31, 2015 | -23.55% |
| December 31, 2014 | -7.53% |
| September 30, 2014 | -62.69% |
| June 30, 2014 | -174.6% |
| March 31, 2014 | -13.03% |
| December 31, 2013 | 6.23% |
| September 30, 2013 | 20.78% |
| June 30, 2013 | -88.65% |
| March 31, 2013 | 3.85% |
| December 31, 2012 | 4.98% |
| September 30, 2012 | 19.83% |
| June 30, 2012 | -101.9% |
| March 31, 2012 | -11.43% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-250.1%
Minimum
Dec 2023
26.29%
Maximum
Mar 2022
-43.34%
Average
-14.87%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 3.20% |
| XWELL Inc | -21.50% |
| Applied DNA Sciences Inc | -- |
| Veracyte Inc | 5.01% |
| OncoCyte Corp | -4.36K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.79% |
| Return on Assets | -28.70% |
| Return on Invested Capital | -42.78% |
| Gross Profit Margin (Quarterly) | -19.24% |
| Operating Margin (Quarterly) | -316.4% |
| Return on Net Operating Assets | -35.02% |